Literature DB >> 18692338

Water-soluble loratadine inclusion complex: analytical control of the preparation by microwave irradiation.

A Nacsa1, R Ambrus, O Berkesi, P Szabó-Révész, Z Aigner.   

Abstract

The majority of active pharmaceutical ingredients are poorly soluble in water. The rate-determining step of absorption is the dissolution of these drugs. Inclusion complexation with cyclodextrin derivatives can lead to improved aqueous solubility and bioavailability of pharmacons due to the formation of co-crystals through hydrogen-bonding between the components. Inclusion complexes of loratadine were prepared by a convenient new method involving microwave irradiation and the products were compared with those of a conventional preparation method. Dissolution studies demonstrated that the solubility and rate of dissolution of loratadine increased in both of the methods used. The interactions between the components were investigated by thermal analysis and Fourier Transform Infrared studies. The microwave treatment did not cause any chemical changes in the loratadine molecule.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18692338     DOI: 10.1016/j.jpba.2008.07.001

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  Thermally triggered mucoadhesive in situ gel of loratadine: β-cyclodextrin complex for nasal delivery.

Authors:  Reena M P Singh; Anil Kumar; Kamla Pathak
Journal:  AAPS PharmSciTech       Date:  2013-01-29       Impact factor: 3.246

2.  Investigating the use of liquisolid compacts technique to minimize the influence of pH variations on loratadine release.

Authors:  Mazen El-Hammadi; Nisrine Awad
Journal:  AAPS PharmSciTech       Date:  2011-11-19       Impact factor: 3.246

3.  Development, stability and in vitro delivery profile of new loratadine-loaded nanoparticles.

Authors:  Jesus Rafael Rodriguez Amado; Ariadna Lafourcade Prada; Jonatas Lobato Duarte; Hady Keita; Heitor Rivero da Silva; Adriana Maciel Ferreira; Edgar Hernandez Sosa; Jose Carlos Tavares Carvalho
Journal:  Saudi Pharm J       Date:  2017-07-19       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.